US 8,445,495 · Application 12/483,093 · Granted May 21, 2013
US 8,445,495
Certain chemical entities, compositions and methods
Estimated expiration
July 30, 2026
Expired 60 days ago
Earliest effective filing
Dec 14, 2006
+ 20 years
Dec 14, 2026
PTA +435d
Feb 22, 2028
TD cap (US 8,101,617)
Jul 30, 2026
Final
Jul 30, 2026
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- June 11, 2009
- Earliest effective filing
- December 14, 2006
- Issue date
- May 21, 2013
- PTA
- +435 days
- Base expiry (before PTA)
- December 14, 2026
December 14, 2006 + 20 years = December 14, 2026 + 435 PTA days = February 22, 2028
- Continuation of application 11/640,438, filed Dec 14, 2006
- PRO60/751,400 — Provisional — not used for base term
- PRO60/756,356 — Provisional — not used for base term
- PRO60/817,975 — Provisional — not used for base term
- PRO60/751,400 — Provisional — not used for base term
- PRO60/756,356 — Provisional — not used for base term
- PRO60/817,975 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to July 30, 2026 (earliest expiring referenced patent: US 8,101,617)
US 7,989,455· Application 11/640,476Capping patent
Compounds, compositions and methods
- Filing date
- Dec 14, 2006
- Earliest effective filing
- Dec 14, 2006
- Issue date
- Aug 2, 2011
- PTA
- +1265 days
- Calculated expiration
- Jun 1, 2030
Dec 14, 2006 + 20y + 1265d PTA = Jun 1, 2030
US 7,507,735· Application 11/155,940Capping patent
Compounds, compositions and methods
- Filing date
- Jun 16, 2005
- Earliest effective filing
- Jun 16, 2005
- Issue date
- Mar 24, 2009
- PTA
- +605 days
- Calculated expiration
- Feb 11, 2027
Jun 16, 2005 + 20y + 605d PTA = Feb 11, 2027
US 8,101,617· Application 12/238,313Capping patent
Disubstituted ureas and uses thereof in treating heart failure
- Filing date
- Sep 25, 2008
- Earliest effective filing
- Jun 16, 2005
- Issue date
- Jan 24, 2012
- PTA
- +409 days
- Calculated expiration
- Jul 30, 2026
Continuation of 11/155,940, filed Jun 16, 2005, issued as US 7,507,735
Jun 16, 2005 + 20y + 409d PTA = Jul 30, 2026
US 8,445,495· Application 12/483,093(from application 12/483,093)
Certain chemical entities, compositions and methods
- Filing date
- Jun 11, 2009
- Earliest effective filing
- Dec 14, 2006
- Issue date
- May 21, 2013
- PTA
- +435 days
- Calculated expiration
- Feb 22, 2028
Continuation of 11/640,438, filed Dec 14, 2006
Dec 14, 2006 + 20y + 435d PTA = Feb 22, 2028
US 8,101,617· Application 12/238,313(from application 12/238,313)
Disubstituted ureas and uses thereof in treating heart failure
- Filing date
- Sep 25, 2008
- Earliest effective filing
- Jun 16, 2005
- Issue date
- Jan 24, 2012
- PTA
- +409 days
- Calculated expiration
- Jul 30, 2026
Continuation of 11/155,940, filed Jun 16, 2005, issued as US 7,507,735
Jun 16, 2005 + 20y + 409d PTA = Jul 30, 2026
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 12/483,093 · US 8,445,495
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 8,445,495: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US8445495Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.